文献速递心脑血管急症

中等血管闭塞卒中的血管内治疗

Endovascular Treatment of Medium-Vessel-Occlusion Strokes.
PubMed 文献 · N Engl J Med · 2026-01-01
一句话结论中等血管闭塞、NIHSS≥6分的卒中患者,取栓加药物管理较单纯药物管理提高90天功能独立率(58.6% vs 46.6%),但症状性颅内出血发生率更高。

该开放标签、终点盲法评估的随机试验在中国48个中心纳入中型血管闭塞、NIHSS评分≥6分、发病24小时内的卒中患者,1:1随机接受取栓加药物管理(取栓组280例)或单纯药物管理(对照组283例)。因违反比例优势假设,预设主要终点改为90天功能独立(改良Rankin量表0-2分),取栓组58.6% vs 对照组46.6%(校正率比1.24,95%CI 1.07-1.44,P=0.004)。症状性颅内出血取栓组4.7% vs 对照组2.2%,90天死亡率11.1% vs 10.2%。结论提示取栓可提高功能独立可能性,但症状性颅内出血风险更高。

要点

  • 中型血管闭塞、NIHSS≥6分、发病24小时内的卒中患者,取栓组90天功能独立率58.6% vs 对照组46.6%(校正率比1.24,95%CI 1.07-1.44,P=0.004)。
  • 取栓组症状性颅内出血发生率4.7% vs 对照组2.2%,90天死亡率11.1% vs 10.2%。
  • 该试验因违反比例优势假设,预设主要终点由改良Rankin量表移位改为90天功能独立(改良Rankin量表0-2分)。
  • 研究纳入中国48个中心、280例取栓组与283例对照组患者,中位年龄71岁、中位NIHSS 10分(范围3-36)、女性42.8%、36.6%接受静脉溶栓。

适用人群与场景

  • 成人中型血管闭塞所致急性缺血性卒中,NIHSS评分≥6分(量表0-42分,分数越高神经功能缺损越重),发病24小时内。
  • 中位年龄71岁,中位NIHSS 10分(范围3-36),女性42.8%,36.6%接受静脉溶栓。

诊断标准与关键阈值

  • 中型血管闭塞,NIHSS评分≥6分,发病24小时内。
  • 主要终点为90天功能独立,定义为改良Rankin量表评分0、1或2分(量表0分无残疾至6分死亡)。

处置流程与药物剂量

  • 取栓组:血管内取栓加药物管理;对照组:单纯药物管理。
  • 随机分组比例1:1。

红旗征与不能漏的情况

  • 症状性颅内出血:取栓组4.7% vs 对照组2.2%。
  • 90天死亡:取栓组11.1% vs 对照组10.2%。

研究设计与关键结果

  • 开放标签、终点盲法评估的随机试验,中国48个中心,取栓组280例、对照组283例。
  • 90天功能独立:取栓组58.6% vs 对照组46.6%(校正率比1.24,95%CI 1.07-1.44,P=0.004)。
  • 症状性颅内出血:取栓组4.7% vs 对照组2.2%;90天死亡率:取栓组11.1% vs 对照组10.2%。
  • 因违反比例优势假设,预设主要终点由改良Rankin量表评分移位改为90天功能独立。

证据类型、等级与局限

  • 证据类型:开放标签、终点盲法评估的随机试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于中型血管闭塞、NIHSS≥6分、发病24小时内的急性缺血性卒中患者,取栓加药物管理较单纯药物管理提高90天功能独立率,但症状性颅内出血风险更高。

指南或共识出处

  • ORIENTAL-MeVO试验(ClinicalTrials.gov注册号NCT06146790),由国家自然科学基金和非传染性慢性病国家科技重大专项资助。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Endovascular thrombectomy for acute ischemic stroke due to medium-vessel occlusion has had varying results across trials. Whether thrombectomy improves functional outcomes in patients with medium-vessel occlusion and moderate-to-severe deficits is unclear.

METHODS: We conducted an open-label, randomized trial with blinded outcome assessment at 48 centers in China. Eligible patients were adults who presented within 24 hours after the onset of a moderate-to-severe stroke (National Institutes of Health Stroke Scale [NIHSS] score, ≥6; scale, 0 to 42, with higher scores indicating greater neurologic deficits) due to occlusion of a medium vessel. Patients were assigned in a 1:1 ratio to thrombectomy plus medical management (thrombectomy group) or medical management alone (control group). The primary outcome was functional disability as measured by the shift in the modified Rankin scale score (scale, 0 [no disability] to 6 [death]) at 90 days. Violation of the proportional-odds assumption precluded the use of shift in the modified Rankin scale score, so as prespecified, functional independence (modified Rankin scale score of 0, 1, or 2) at 90 days was used as the primary outcome. Safety outcomes were symptomatic intracranial hemorrhage and 90-day mortality.

RESULTS: Among 280 patients in the thrombectomy group and 283 in the control group, the median age was 71 years, the median NIHSS score was 10 (range, 3 to 36), and 42.8% were women; 36.6% received intravenous thrombolysis. Functional independence at 90 days was seen in 58.6% of the patients in the thrombectomy group and in 46.6% of those in the control group (adjusted rate ratio, 1.24; 95% confidence interval, 1.07 to 1.44; P = 0.004). The incidence of symptomatic intracranial hemorrhage was 4.7% in the thrombectomy group and 2.2% in the control group; 90-day mortality was 11.1% and 10.2%, respectively.

CONCLUSIONS: Among patients with acute ischemic stroke due to medium-vessel occlusion and moderate-to-severe deficits, thrombectomy led to a greater likelihood of functional independence than medical management alone but also to a higher risk of symptomatic intracranial hemorrhage. (Funded by the National Natural Science Foundation of China and the Noncommunicable Chronic Diseases-National Science and Technology Major Project; ORIENTAL-MeVO ClinicalTrials.gov number, NCT06146790.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Hu W, Jing X, Chen Z, et al. Endovascular Treatment of Medium-Vessel-Occlusion Strokes. N Engl J Med. 2026. PMID: 42127389. doi:10.1056/NEJMoa2514120

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。